In contrast, FHH, caused by mutations in CASR, GNA11, or AP2S1, is typically a benign condition that does not benefit from parathyroidectomy and must be distinguished from PHPT to avoid unnecessary surgery (98). This evidence concerns the gene CASR and familial hypocalciuric hypercalcemia.